Risk factors and prevention of dabigatran-related gastrointestinal bleeding in patients with atrial fibrillation.

Teerapat NantsupawatSuthipong SoontrapaNopakoon NantsupawatDavid SotelloSaranapoom KlomjitSelcuk AdabagAlejandro Perez-Verdia

Published in: Journal of arrhythmia (2017)

In this real-world cohort, PPI/H2RA use was not associated with reduced GIB events. HAS-BLED score ≥3 and prior history of GIB within 1 year are independent risk factors for GIB among dabigatran users.

Keyphrases

risk factors
atrial fibrillation
rheumatoid arthritis
disease activity
ankylosing spondylitis
protein protein
systemic lupus erythematosus
interstitial lung disease